{"name":"Shanghai HEP Pharmaceutical Co., Ltd.","slug":"shanghai-hep-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Placebo of Hepalatide","genericName":"Placebo of Hepalatide","slug":"placebo-of-hepalatide","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Placebo of Hepalatide","genericName":"Placebo of Hepalatide","slug":"placebo-of-hepalatide","phase":"phase_3","mechanism":"This is a placebo control formulation used in clinical trials and does not exert any active pharmacological effect.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNYk5fUTdiZXJyZXNiS3ZQc1ZYRldqQ1BKQ2tEcVdqRlZ1U0o2dzNLSEwyU2o3czBDVnpKWC1aYnFJMVNUZ0hDZFRpS2trZGpzUGRJcXltYXoxYWdaLXhzems0VG1ObS1sRzdmUmJ1OFpnSHVwcXpCQXlvdVcxcjJOTWlVTHllcFZRWWItWGJneXI3cGdVb3lXS0RRRktkS0xYMGNqcTY2eXRWTHBTM0NrTGJvRjN6a2ctZWlKTzQyZFZMNWlTWDU1SzZINjh4bVdOVkUxMHhhSjAzX2QxZWMxUDM3MUxSbXVmdkJ2aFhZWGRKbU5IR19kVTN2WVJOSTZkOHpRWWdoVnFFTnNhaGc?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPdWZTVlZCX2FTY3Z6TDBuQmc0SGhadFgzekZieFZPM1pKQ1VpWjFIMnN6NEk0UWhXVUFSbVZVenhMa2RJU2d4dFo2ZmtvLTFXRnNsYm1STjc5ZXFMVmtNdzV0N1ZJUTZBODJnMkNCS0J6c2Z0amdZYXBGV0pLS1JuNUNlUXRVaklpRnItOHJKdGRFTkVSUTZRQmhYbGd0TG8taHc?oc=5","date":"2026-03-27","type":"pipeline","source":"The Pharma Letter","summary":"GSK returns Engerix B to China via Shanghai Pharma tie-up | Pharmaceutical | The Pharmaletter - The Pharma Letter","headline":"GSK returns Engerix B to China via Shanghai Pharma tie-up | Pharmaceutical | The Pharmaletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOZ1llTFI5SGdCSTJtX2Z0M0ZXaXFZQXNOaFRLUnhaV3g5aFp4V3RCa0Z2T0J6eHUtS3JRMmxDdG9qMUxUb1d0b0VBOGpKSUczUzJSZUtWalRqckk3UUpxdEo2aXplY3MzZlpMaVRXc0g3TzdPSVlwcEJDNDRhTm9kak1wUVh3ZGdBM2lKd19TNmJTekNsOHVoNUhmNjd0VnV0NllkRg?oc=5","date":"2026-01-29","type":"patent","source":"BioWorld News","summary":"Hengrui Pharmaceuticals patent reports Nav1.8 channel blockers - BioWorld News","headline":"Hengrui Pharmaceuticals patent reports Nav1.8 channel blockers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQZ1BfUTVMbEswQjNqQ1BvQURVX09jaUxqM1g3bXVZVmFkMFNKenA4c2l4alpuQUQtZTQ4QUxqc05yd2hzMmsza0hucmlXelFQYXZQa00tX29GeVlvN0JQcUJYVXVwbXpIRXJMRmNlRnVGQnhrSzFvUlV5R2VUS09zc3J3T05rU0lVOHNzTFFfNEtGYmg1aFNmNmtVZEY4M2FIUU11RjVkSzJ0U3ByWEtxSmYxSjRvanc?oc=5","date":"2025-12-24","type":"deal","source":"Reuters","summary":"Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal - Reuters","headline":"Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPeHhraXd4RzZOUG9kNXg0YTRtNHFtNi1ROEN3T01LNDRwbXBJYXlJZEphUWFIaUFTRnN1VWhTV3JQTVhUMW1mbU5LTERCZFVZWFBqVW04UkN4alNPXzI5VjMzNVFtT0QwVHRtYlVZMkxHVVVGNTZwWjQtMHRLbWVyRkVXMzFIaTR3VlF1X3FBUDh4ZENyclJtVDFjSHBwNDZXUUFnMGM0U2hYRHAzSUE?oc=5","date":"2025-12-15","type":"deal","source":"Bloomberg.com","summary":"Fosun Pharma Inks Deal to Revive Botched China Alzheimer Drug - Bloomberg.com","headline":"Fosun Pharma Inks Deal to Revive Botched China Alzheimer Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOSjFjalBDX2E2ZXoyUmo5YXZaQThKeXhvUXBNMElJUHVjNTZWMGxlaHBqM0NuQ3FJN3piajlpZ1QyMm53d2w0eHhlUmNabVZHRjFtUERaWXVTaUtLV2cweDJSaE83ZGpOSV9kMmlQOVhwTzlZU0pKcUFWd1lmYTA5YjlyWUk4SUdpTGowWGVVQ0hYdWt0eXdyYmdjRk95RHd5Y0g0cWcyc0xOMGlxNUdkODJlTHl4OG9hZUxIMi1zYVF4N0ZrY0hYa2VGRGxkS0NHSGc?oc=5","date":"2025-12-09","type":"deal","source":"businesswire.com","summary":"Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma - businesswire.com","headline":"Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9sRGtDWXZSVVk3OEQzQm4tUXVGekRTRlluQVpnRk9KeE9pd2RuSkVHU3FVazlKTnJQTU5FXzA5YzFacGd6ODM1M0xxcEtPSXhEaFAw?oc=5","date":"2025-11-29","type":"deal","source":"36 Kr","summary":"Institutions are \"buying the dip\" in the assets of multinational pharmaceutical companies. - 36 Kr","headline":"Institutions are \"buying the dip\" in the assets of multinational pharmaceutical companies. - 36 Kr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPWER1VnZpYThnbk1ETFl4TmZwUFZVT2xDTEM1YUNKZDNlTXF4eVlsaFotczliNF9IM2xtNXkzUUgxM2NMcU9xRXNYRGQ5VldvdnJSb09GR2I0N0JCdnU5UTBsYi0tUmcxWGEySFdWZ2lwekRWejZ2Z0o0X2FRSDI0bjJBSERxbjJoQ0tQR3N3TlAyNDJYNEw2ZGFMVHlVamhIQlByZjU0RVQ4Y3prV0hyRVVOdDZVdzhwODRNbEtZYTd2aW8zLWpYeUItbXVFOXF5NFlPYmdVRGl6TF9t?oc=5","date":"2025-10-22","type":"deal","source":"Reuters","summary":"China's Innovent signs cancer therapy deal with Japan's Takeda - Reuters","headline":"China's Innovent signs cancer therapy deal with Japan's Takeda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOd1p5eUVSN2hiWWtQVTRtdUpxaWExSXZ6OHJfd3U4eFVrWFdxeGtLMlNUa2diSFZBeFZ2bTJQb1U4Z3pVNDQzRldaMUhtSVQ1bHZMY0FabXZaOUhBNFV3bDI1NEdnWC0zaXhuWmRmRXFVMzJIc29hMmlFeU5Pd0QxYzRUWTkzbVE?oc=5","date":"2025-09-19","type":"pipeline","source":"BioWorld News","summary":"Genfleet raises $234M with Hong Kong IPO - BioWorld News","headline":"Genfleet raises $234M with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOeG5KMmdyWTFGSDRpNk5vby1zVmEwV3hZZzhXcnNQME84aVh2R2Q0TmJWNDBOMXFFa05XMjQwbl9kaG1HRkJndUF5TmJ4eXBSejdyb3dXOVd2X2VTYkQ5bnhCWGNNeXp5SWltZUFDQWV0X09vUVdRbDI1YjVzRTgzOWlFUEJWY2FERUdRaGdmR0RfZjRVZ3BKNg?oc=5","date":"2025-07-26","type":"trial","source":"JLL","summary":"Life Science Industrial Park - development in Shanghai - JLL","headline":"Life Science Industrial Park - development in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU0RZUHNRWE1TblRiVlhDR3NlSEdybl9DTmY1ZDA3R29vVE1OaTNhZ1ZVZ3J4ajA1ZGpPWlBWRXBHTkVOT0JXcE53N1dHZnBvdEVLa19yeGRMSTJNT0RVUUdiczNqQUlVcklNN05YRndQOUxEWGpTWUY1V3psbEkzTFgyLU83WUdRcTJJUDIyN3pLcWtwOS1KRG5HWHBuVWgyUVh2TXZ2NjdHdXZ2ZVpYb1FTYjlWcm52?oc=5","date":"2025-05-27","type":"deal","source":"Fierce Pharma","summary":"Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs - Fierce Pharma","headline":"Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gJBVV95cUxQa0xCZHBFYjBKSGZYMHVzYTFpSzQtXzdxUlJzdEFITXc4aVgtTlRjNWtBNU9iWDN6V0xZbXBfUUx4LW52YmdCX3VmaE5UVGROb0RKYlVKRkl6WkVyYjZEdjlCdzIwZE9kMHpUdlpDQ0taZzViSkVfclBOVldKMVVhdmx1cmtiZmkxNWpvSGhvR2dCcVNETGFkQ2s2ajVfQmhURUdlODFDMTM0NTJfOElKSTh6bVJ4TUVTLVMyTGs4UmhtYktyYkhXeEpRZVRVZHE5T2NYS3MwQXhiTHZZcTZ3LUNZMjFuQjN0S1gtMmFEVDBxUUZia0hXYW1PNkZ0ejFYVFpXVFNsMjJ1Q2NoQjRnb3RENFQ4aHVQRHc3U3FtUzVpTkRmdG5jYm0wVmRKbDRObVZDMjVGYW8tWXVER3ZrTTB5NGg5SU92alF5QkJWZHZndmZkUGVQUGJB?oc=5","date":"2021-10-12","type":"deal","source":"prnewswire.com","summary":"Shanghai Pharmaceuticals and Luca Healthcare Announce a Strategic Collaboration to Provide Home Drug Delivery to Rare Disease Patients on Luca Healthcare's Patient Management Platform - prnewswire.com","headline":"Shanghai Pharmaceuticals and Luca Healthcare Announce a Strategic Collaboration to Provide Home Drug Delivery to Rare Di","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}